Glucose metabolism test in ICU patients
Part of Infections, Lungs & breathing clinical trials.
This study is testing how immune cells use sugar (glucose) in people who are in the intensive care unit (ICU). By doing this test, researchers hope to learn more about how the body fights illness during critical care, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be a patient in the Medical or Pulmonary ICU at Vanderbilt University Medical Center.
- You or your legal representative must agree to the genetic testing required for this study.
- You cannot be pregnant, a prisoner, or in police custody.
- You must not have severe anemia (low red blood cells) or uncontrolled high blood sugar.
- You must be able to safely have an IV line placed and have blood drawn for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special sugar (glucose) to see how your immune cells use energy. You drink a labeled sugar, then give blood samples so researchers can track it.
This trial is testing two ways of monitoring blood sugar in intensive care patients: continuous monitoring (a sensor) versus intermittent checks. If you are in the ICU with high blood sugar and on IV insulin, this study might help find a better way to manage your levels.
This study looks at whether a simple blood test ratio can help predict how well critically ill patients do in the intensive care unit (ICU). It aims to understand if stress-related high blood sugar affects recovery.
This study looks at how the body produces energy in critically ill patients on breathing machines. It compares energy production between ICU patients and healthy volunteers to find better ways to support recovery.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This study compares two types of blood tests (from a vein and an artery) to see if they give similar information about oxygen and carbon dioxide levels in critically ill patients, especially those with diabetes. The results may help doctors choose the best way to monitor patients in the ICU.
Hear when a new Glucose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.